Telemark Asset Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-400,000
Closed -$7.21M 56
2025
Q4
$7.21M Sell
400,000
-200,000
-33% -$3.59M 0.72% 46
2025
Q3
$11.1M Buy
600,000
+100,000
+20% +$1.57M 1.06% 35
2025
Q2
$8M Hold
500,000
0.73% 39
2025
Q1
$9.71M Hold
500,000
1.27% 31
2024
Q4
$11M Buy
500,000
+100,000
+25% +$1.92M 1.1% 35
2024
Q3
$6.74M Buy
+400,000
New +$5.94M 0.68% 43
2022
Q1
Sell
-1,000,000
Closed -$8.02M 57
2021
Q4
$8.02M Hold
1,000,000
0.57% 47
2021
Q3
$9.26M Buy
+1,000,000
New +$10.5M 0.67% 48

Other funds holding CLBT

Telemark Asset Management's CLBT Position: Q1 2026 in Review

Telemark Asset Management sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 400,000 shares — an estimated $7.21M sold.

Telemark Asset Management first reported a position in CLBT in Q3 2021 and held it in 8 quarters. The position peaked at $11.1M in Q3 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Telemark Asset Management reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Telemark Asset Management sold 400,000 Cellebrite shares in Q1 2026, an estimated $7.21M.
  • Telemark Asset Management first reported a position in Cellebrite in Q3 2021 and held it in 8 quarters.
  • Telemark Asset Management's Cellebrite position peaked at $11.1M in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Telemark Asset Management's 13F filing for Q1 2026, filed 12 May 2026.